Zobrazeno 1 - 10
of 1 295
pro vyhledávání: '"Meggetto, F"'
Autor:
Bessière C; Cancer Research Center of Toulouse, INSERM UMR-1037, CNRS UMR-5071, Toulouse University, Toulouse, France.; Institute for Regenerative Medicine and Biotherapy, INSERM UMR-1183, Saint-Éloi Hospital, Montpellier University, Montpellier, France., Zamani A; Cancer Research Center of Toulouse, INSERM UMR-1037, CNRS UMR-5071, Toulouse University, Toulouse, France., Pfeifer R; Cancer Research Center of Toulouse, INSERM UMR-1037, CNRS UMR-5071, Toulouse University, Toulouse, France., Dailhau S; Cancer Research Center of Toulouse, INSERM UMR-1037, CNRS UMR-5071, Toulouse University, Toulouse, France., Marchet C; CRIStAL-Research center in Computer Science, Signal and Automatic Control of Lille, CNRS UMR-9189, Lille University, Villeneuve d'Ascq, France., Guibert B; Institute for Regenerative Medicine and Biotherapy, INSERM UMR-1183, Saint-Éloi Hospital, Montpellier University, Montpellier, France., Boureux A; Institute for Regenerative Medicine and Biotherapy, INSERM UMR-1183, Saint-Éloi Hospital, Montpellier University, Montpellier, France., Silva Da Silva R; Institute for Regenerative Medicine and Biotherapy, INSERM UMR-1183, Saint-Éloi Hospital, Montpellier University, Montpellier, France., Gilbert N; Institute for Regenerative Medicine and Biotherapy, INSERM UMR-1183, Saint-Éloi Hospital, Montpellier University, Montpellier, France., Commes T; Institute for Regenerative Medicine and Biotherapy, INSERM UMR-1183, Saint-Éloi Hospital, Montpellier University, Montpellier, France., Meggetto F; Cancer Research Center of Toulouse, INSERM UMR-1037, CNRS UMR-5071, Toulouse University, Toulouse, France., Touriol C; Cancer Research Center of Toulouse, INSERM UMR-1037, CNRS UMR-5071, Toulouse University, Toulouse, France., Récher C; Hematology Department, University Hospital Center, IUCT-University Cancer Institute, Toulouse, France., Bousquet M; Cancer Research Center of Toulouse, INSERM UMR-1037, CNRS UMR-5071, Toulouse University, Toulouse, France., Pyronnet S; Cancer Research Center of Toulouse, INSERM UMR-1037, CNRS UMR-5071, Toulouse University, Toulouse, France.
Publikováno v:
Cancer communications (London, England) [Cancer Commun (Lond)] 2025 Jan 03. Date of Electronic Publication: 2025 Jan 03.
Autor:
Parravicini, Carlo, Lauri, Eleonora, Baldini, Luca, Neri, Antonino, Poli, Francesca, Sirchia, Girolamo, Moroni, Mauro, Galli, Massimo, Corbellino, Mario, Masood, Rizwan, Zheng, Tong, Tulpule, Anil, Arora, Naveen, Chatlynne, Louise, Handy, Michael, Whitman, James, Kaplan, Mark, Dosik, Michael, Ablashi, Dharam V., Gill, Parkash S., Whitby, Denise, Boshoff, Chris, Luppi, Mario, Torelli, Giuseppe, Cottoni, Francesca, Uccini, Stefania, Brousset, P., Meggetto, F., Attal, M., Delsol, G., Said, J. W., Sun, R., Vescio, R. A., Berenson, J. R.
Publikováno v:
Science, 1997 Dec 01. 278(5345), 1969-1973.
Externí odkaz:
https://www.jstor.org/stable/2894678
Autor:
Fuchs, S., Danßmann, C., Klironomos, F., Winkler, A., Fallmann, J., Kruetzfeldt, L.M., Szymansky, A., Naderi, J., Bernhart, S.H., Grunewald, L., Helmsauer, K., Rodriguez-Fos, E., Kirchner, M., Mertins, P., Astrahantseff, K., Suenkel, C., Toedling, J., Meggetto, F., Remke, M., Stadler, P.F., Hundsdoerfer, P., Deubzer, H.E., Künkele, A., Lang, P., Fuchs, J., Henssen, A.G., Eggert, A., Rajewsky, N., Hertwig, F., Schulte, J.H.
Circular RNAs (circRNAs) are a regulatory RNA class. While cancer-driving functions have been identified for single circRNAs, how they modulate gene expression in cancer is not well understood. We investigate circRNA expression in the pediatric malig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::0964e8da9950d9a20d7a7aa5d5ba71b2
http://edoc.mdc-berlin.de/23576/2/23576suppl.zip
http://edoc.mdc-berlin.de/23576/2/23576suppl.zip
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Capuani, C., Meggetto, F., Duga, I., Danjoux, M., March, M., Parant, O., Brousset, P., Aziza, J.
Publikováno v:
In Placenta February 2013 34(2):149-154
Autor:
Fuchs S; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany. steffen.fuchs@charite.de.; The German Cancer Consortium (DKTK), Partner Site Berlin, 10117, Berlin, Germany. steffen.fuchs@charite.de.; The German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. steffen.fuchs@charite.de.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, 10178, Berlin, Germany. steffen.fuchs@charite.de.; CRCT, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, 31037, Toulouse, France. steffen.fuchs@charite.de.; Laboratoire d'Excellence Toulouse Cancer-TOUCAN, 31037, Toulouse, France. steffen.fuchs@charite.de., Danßmann C; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany., Klironomos F; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany., Winkler A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany., Fallmann J; Bioinformatics Group, Department of Computer Science, and Interdisciplinary Center for Bioinformatics, University of Leipzig, 04107, Leipzig, Germany., Kruetzfeldt LM; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany., Szymansky A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany., Naderi J; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, 14195, Berlin, Germany., Bernhart SH; Bioinformatics Group, Department of Computer Science, and Interdisciplinary Center for Bioinformatics, University of Leipzig, 04107, Leipzig, Germany., Grunewald L; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, 10117, Berlin, Germany.; The German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Helmsauer K; Experimental and Clinical Research Center (ECRC) of the Charité and Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125, Berlin, Germany., Rodriguez-Fos E; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.; Experimental and Clinical Research Center (ECRC) of the Charité and Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125, Berlin, Germany., Kirchner M; Core Unit Proteomics, Berlin Institute of Health at Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine (MDC), 13125, Berlin, Germany., Mertins P; Core Unit Proteomics, Berlin Institute of Health at Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine (MDC), 13125, Berlin, Germany., Astrahantseff K; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany., Suenkel C; Systems Biology of Gene Regulatory Elements, Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Hannoversche Straße 28, 10115, Berlin, Germany.; Lonza Drug Product Services, 4057, Basel, Switzerland., Toedling J; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, 10117, Berlin, Germany.; The German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Meggetto F; CRCT, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, 31037, Toulouse, France.; Laboratoire d'Excellence Toulouse Cancer-TOUCAN, 31037, Toulouse, France., Remke M; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich Heine University Düsseldorf, Medical Faculty, and University Hospital Düsseldorf, 40225, Düsseldorf, Germany.; The German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, 40225, Düsseldorf, Germany.; Institute of Neuropathology, Heinrich Heine University Düsseldorf, Medical Faculty, and University Hospital Düsseldorf, 40225, Düsseldorf, Germany., Stadler PF; Bioinformatics Group, Department of Computer Science, and Interdisciplinary Center for Bioinformatics, University of Leipzig, 04107, Leipzig, Germany., Hundsdoerfer P; Department of Pediatric Oncology, Helios Klinikum Berlin-Buch, 13125, Berlin, Germany., Deubzer HE; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, 10117, Berlin, Germany.; The German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, 10178, Berlin, Germany.; Experimental and Clinical Research Center (ECRC) of the Charité and Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125, Berlin, Germany., Künkele A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, 10117, Berlin, Germany.; The German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Lang P; Department I - General Pediatrics, Hematology/Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, 72076, Tuebingen, Germany., Fuchs J; Department of Pediatric Surgery and Pediatric Urology, University Children's Hospital, Eberhard Karls University Tuebingen, 72076, Tuebingen, Germany., Henssen AG; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, 10117, Berlin, Germany.; The German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Experimental and Clinical Research Center (ECRC) of the Charité and Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125, Berlin, Germany., Eggert A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, 10117, Berlin, Germany.; The German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, 10178, Berlin, Germany., Rajewsky N; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.; Systems Biology of Gene Regulatory Elements, Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Hannoversche Straße 28, 10115, Berlin, Germany., Hertwig F; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, 10117, Berlin, Germany.; The German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Schulte JH; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany. johannes.schulte@med.uni-tuebingen.de.; The German Cancer Consortium (DKTK), Partner Site Berlin, 10117, Berlin, Germany. johannes.schulte@med.uni-tuebingen.de.; The German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. johannes.schulte@med.uni-tuebingen.de.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, 10178, Berlin, Germany. johannes.schulte@med.uni-tuebingen.de.; Department I - General Pediatrics, Hematology/Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, 72076, Tuebingen, Germany. johannes.schulte@med.uni-tuebingen.de.
Publikováno v:
Nature communications [Nat Commun] 2023 Jul 04; Vol. 14 (1), pp. 3936. Date of Electronic Publication: 2023 Jul 04.
Autor:
Troadec MB; Univ Brest, INSERM, EFS, UMR 1078, GGB, 29200 Brest, France; CHRU Brest, Service de génétique, laboratoire de génétique chromosomique, Brest, France. Electronic address: marie-berengere.troadec@univ-brest.fr., Porteu F; Institut Gustave Roussy, INSERM UMR 1287, Villejuif, France., Arcangeli ML; Université Côte d'Azur (UCA), C3M, INSERM U1065, 151 Route de St Antoine de Ginestière, BP2 3194, 06204 Nice cedex 03, France., Foudi A; INSERM UMRS 935, Institut André Lwoff, Villejuif, France., Bluteau D; Ecole Pratique des Hautes Etudes, Université PSL, INSERM UMR9019 CNRS/Paris Saclay/Institut Gustave Roussy/EPHE, Villejuif, France., De Sepulveda P; CRCM, INSERM U1068, Institut Paoli-Calmettes, CNRS, Aix-Marseille Université, Marseille, France., Guillouf C; INSERM U1170, Institut Gustave Roussy, 94800 Villejuif, France., Mazure NM; Université Côte d'Azur (UCA), C3M, INSERM U1065, 151 Route de St Antoine de Ginestière, BP2 3194, 06204 Nice cedex 03, France., Meggetto F; CRCT, INSERM UMR 1037, CNRS UMR 5071, Toulouse III University-Paul Sabatier, Toulouse, France., Brunet De La Grange P; Établissement Français du Sang Nouvelle Aquitaine, France., Broccardo C; CRCT, INSERM UMR 1037, CNRS UMR 5071, Toulouse III University-Paul Sabatier, Toulouse, France.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2023 Mar; Vol. 110 (3), pp. 331-335. Date of Electronic Publication: 2023 Feb 10.
Autor:
Fuchs S; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health at Charité -Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany.; CRCT, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Toulouse, France.; Laboratoire d'Excellence Toulouse Cancer-TOUCAN, Toulouse, France., Babin L; CRCT, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Toulouse, France.; Laboratoire d'Excellence Toulouse Cancer-TOUCAN, Toulouse, France., Andraos E; CRCT, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Toulouse, France.; Laboratoire d'Excellence Toulouse Cancer-TOUCAN, Toulouse, France., Bessiere C; CRCT, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Toulouse, France.; Laboratoire d'Excellence Toulouse Cancer-TOUCAN, Toulouse, France., Willier S; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany., Schulte JH; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health at Charité -Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany., Gaspin C; INRAE, BioinfOmics, GenoToul Bioinformatics Facility, Université Fédérale de Toulouse, Castanet-Tolosan, France.; INRAE, MIAT, Université Fédérale de Toulouse, Castanet-Tolosan, France., Meggetto F; CRCT, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Toulouse, France.; Laboratoire d'Excellence Toulouse Cancer-TOUCAN, Toulouse, France.
Publikováno v:
PloS one [PLoS One] 2022 Sep 07; Vol. 17 (9), pp. e0273253. Date of Electronic Publication: 2022 Sep 07 (Print Publication: 2022).
Autor:
Babin L; Laboratory of the « Genome Dynamics in the Immune System », Équipe Labellisée La Ligue Contre Le Cancer, Université de Paris, Université Paris Saclay, INSERM UMR 1163, Institut Imagine, Paris, France., Darchen A; Laboratory of the « Genome Dynamics in the Immune System », Équipe Labellisée La Ligue Contre Le Cancer, Université de Paris, Université Paris Saclay, INSERM UMR 1163, Institut Imagine, Paris, France., Robert E; Programme PEDIAC, Equipe labellisée Ligue Contre le Cancer, OPALE Carnot Institute, Université Paris Saclay, INSERM Unité U1170, Gustave Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94805, Villejuif, France., Aid Z; Programme PEDIAC, Equipe labellisée Ligue Contre le Cancer, OPALE Carnot Institute, Université Paris Saclay, INSERM Unité U1170, Gustave Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94805, Villejuif, France., Borry R; Laboratory of the « Genome Dynamics in the Immune System », Équipe Labellisée La Ligue Contre Le Cancer, Université de Paris, Université Paris Saclay, INSERM UMR 1163, Institut Imagine, Paris, France., Soudais C; Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Université de Paris, INSERM UMR1163, Institut Imagine, Paris, France., Piganeau M; INSERM U1154, CNRS UMR 7196, Sorbonne Universités, Museum National d'Histoire Naturelle, 43 rue Cuvier, F-75231, Paris, France., De Cian A; INSERM U1154, CNRS UMR 7196, Sorbonne Universités, Museum National d'Histoire Naturelle, 43 rue Cuvier, F-75231, Paris, France., Giovannangeli C; INSERM U1154, CNRS UMR 7196, Sorbonne Universités, Museum National d'Histoire Naturelle, 43 rue Cuvier, F-75231, Paris, France., Bawa O; PETRA platform, AMMICa, University Paris Saclay, CNRS-UMS 3655 Inserm US23, Gustave Roussy, 94805, Villejuif, France., Rigaud C; Department of Pediatric and Adolescent Oncology, Gustave Roussy, 94805, Villejuif, France., Scoazec JY; Department of Pathology, AMMICa CNRS UMS3655 Inserm US23 Université Paris Saclay, Gustave Roussy, 94805, Villejuif, France., Couronné L; Laboratory of Onco Hematology, Hôpital Necker - Enfants Malades, Assistance Publique Hôpitaux de Paris (APHP); Laboratory of Normal and pathological lymphoid differentiation, University of Paris, INSERM U1151, INEM Institute, Paris, France., Veleanu L; Université de Paris, Institut Necker-Enfants Malades (INEM), INSERM U1151, and Laboratory of Onco-Hematology, AP-HP Hôpital Necker Enfants-Malades, Paris, France., Cieslak A; Université de Paris, Institut Necker-Enfants Malades (INEM), INSERM U1151, and Laboratory of Onco-Hematology, AP-HP Hôpital Necker Enfants-Malades, Paris, France., Asnafi V; Université de Paris, Institut Necker-Enfants Malades (INEM), INSERM U1151, and Laboratory of Onco-Hematology, AP-HP Hôpital Necker Enfants-Malades, Paris, France., Sibon D; Université de Paris, Institut Necker-Enfants Malades (INEM), INSERM U1151, and Laboratory of Onco-Hematology, AP-HP Hôpital Necker Enfants-Malades, Paris, France., Lamant L; Université Toulouse III-Paul Sabatier, Laboratoire d'Excellence Toulouse Cancer-TOUCAN, Équipe Labellisée La Ligue Contre Le Cancer, CNRS UMR5071, Inserm, UMR1037, CRCT, F-31000, Toulouse, France., Meggetto F; Université Toulouse III-Paul Sabatier, Laboratoire d'Excellence Toulouse Cancer-TOUCAN, Équipe Labellisée La Ligue Contre Le Cancer, CNRS UMR5071, Inserm, UMR1037, CRCT, F-31000, Toulouse, France., Mercher T; Programme PEDIAC, Equipe labellisée Ligue Contre le Cancer, OPALE Carnot Institute, Université Paris Saclay, INSERM Unité U1170, Gustave Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94805, Villejuif, France. thomas.mercher@inserm.fr., Brunet E; Laboratory of the « Genome Dynamics in the Immune System », Équipe Labellisée La Ligue Contre Le Cancer, Université de Paris, Université Paris Saclay, INSERM UMR 1163, Institut Imagine, Paris, France. erika.brunet@inserm.fr.
Publikováno v:
Molecular cancer [Mol Cancer] 2022 Mar 04; Vol. 21 (1), pp. 65. Date of Electronic Publication: 2022 Mar 04.
Autor:
Babin L; CRCT INSERM, UMR1037, Toulouse, France.; Toulouse III University-Paul Sabatier, UMR1037 INSERM, UMR5071 CNRS, Toulouse, France.; The Toulouse Cancer Laboratory of Excellence (TOUCAN), Toulouse, France., Andraos E; CRCT INSERM, UMR1037, Toulouse, France.; Toulouse III University-Paul Sabatier, UMR1037 INSERM, UMR5071 CNRS, Toulouse, France.; The Toulouse Cancer Laboratory of Excellence (TOUCAN), Toulouse, France., Fuchs S; CRCT INSERM, UMR1037, Toulouse, France.; Toulouse III University-Paul Sabatier, UMR1037 INSERM, UMR5071 CNRS, Toulouse, France.; The Toulouse Cancer Laboratory of Excellence (TOUCAN), Toulouse, France.; Department of Pediatric Oncology, Charité University Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany., Pyronnet S; CRCT INSERM, UMR1037, Toulouse, France.; Toulouse III University-Paul Sabatier, UMR1037 INSERM, UMR5071 CNRS, Toulouse, France.; The Toulouse Cancer Laboratory of Excellence (TOUCAN), Toulouse, France., Brunet E; Imagine Institute INSERM Joint Research Unit 1163, Laboratory of Genome Dynamics in the Immune System, Paris, France.; Paris Descartes-Sorbonne University, Imagine Institute, Paris, France., Meggetto F; CRCT INSERM, UMR1037, Toulouse, France.; Toulouse III University-Paul Sabatier, UMR1037 INSERM, UMR5071 CNRS, Toulouse, France.; The Toulouse Cancer Laboratory of Excellence (TOUCAN), Toulouse, France.
Publikováno v:
JCI insight [JCI Insight] 2021 Nov 08; Vol. 6 (21). Date of Electronic Publication: 2021 Nov 08.